Skip to content
10-K/A

Annual Report

KAIROS PHARMA, LTD. KAPA

0001641172-25-021134

← back to feed
Filed
Jul 28, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jul 28, 2025 20.46M sh